DRD2 expression based on 18F-fallypride PET/MR predicts the dopamine agonist resistance of prolactinomas: a pilot study
Hao Tang, Yijun Cheng, Xiaohui Lou, Hong Yao, Jing Xie, Weiting Gu, Xin‐Yun Huang, Yanting Liu, Shaojian Lin, Yuting Dai, Xue Li, Xiaozhu Lin, Zhe Wu
Topics & Concepts
ImmunohistochemistryProlactinomaMedicineDopamineNuclear medicineDopamine agonistAgonistPositron emission tomographyStandardized uptake valueInternal medicineProlactinDopaminergicHormoneReceptorPituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsAdrenal and Paraganglionic Tumors